<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Next Geniq Stats - Latest Endothelin Receptor Antagonists (ERAs) News &amp; Blogs</title>
    <link>https://www.nextgeniqstats.com/topic/Endothelin%20Receptor%20Antagonists%20%28ERAs%29</link>
    <description>Stay updated with the latest Endothelin Receptor Antagonists (ERAs) articles, blogs, and stories from Next Geniq Stats</description>
    <language>en-US</language>
    <lastBuildDate>Thu, 16 Oct 2025 08:03:25 GMT</lastBuildDate>
    <managingEditor>salgaresagar20@gmail.com (Next Geniq Stats)</managingEditor>
    <webMaster>salgaresagar20@gmail.com (Next Geniq Stats)</webMaster>
    <ttl>15</ttl>
    <generator>Keynate Topic RSS Generator</generator>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.nextgeniqstats.com/topic/Endothelin%20Receptor%20Antagonists%20%28ERAs%29/rss" rel="self" type="application/rss+xml" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.nextgeniqstats.com/topic/Endothelin%20Receptor%20Antagonists%20%28ERAs%29" rel="alternate" type="text/html" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" rel="hub" href="https://pubsubhubbub.appspot.com/" />
    <image>
      <title>Next Geniq Stats - Latest Endothelin Receptor Antagonists (ERAs) News &amp; Blogs</title>
      <url>https://www.nextgeniqstats.com/apple-touch-icon.png</url>
      <link>https://www.nextgeniqstats.com/topic/Endothelin%20Receptor%20Antagonists%20%28ERAs%29</link>
      <width>96</width>
      <height>96</height>
    </image>
    <item>
      <title>Pulmonary Arterial Hypertension Market Size &amp; Trends | 2024-2035 Research Report</title>
      <link>https://www.nextgeniqstats.com/news/Pulmonary-Arterial-Hypertension-Market-Size-Trends-2024-2035-Research-Report</link>
      <description>&lt;a href="https://www.nextgeniqstats.com/news/Pulmonary-Arterial-Hypertension-Market-Size-Trends-2024-2035-Research-Report"&gt;&lt;img alt="Pulmonary Arterial Hypertension Market Size &amp; Trends | 2024-2035 Research Report" src="https://www.nextgeniqstats.com/view/nextgen/images-16.jpg"&gt;&lt;/a&gt;&lt;p&gt;Explore the Pulmonary Arterial Hypertension (PAH) market with a detailed analysis of its size, key growth drivers, emerging trends, competitive landscape, and future outlook for the period 2024-2035.&lt;/p&gt;</description>
      <category>endothelin receptor antagonists</category>
      <category>PDE5 inhibitors</category>
      <category>prostacyclin and prostacyclin analogs</category>
      <category>soluble guanylate cyclase sGC stimulators</category>
      <category>sotatercept</category>
      <category>oral therapies</category>
      <category>intravenous therapies</category>
      <category>drug class segmentation</category>
      <category>regional analysis</category>
      <category>Pulmonary Arterial Hypertension Market size</category>
      <category>PAH drug class segmentation</category>
      <category>PAH regional analysis</category>
      <category>prostacyclin analogs</category>
      <category>sGC stimulators</category>
      <category>branded PAH drugs</category>
      <category>hospital pharmacies</category>
      <category>online pharmacies</category>
      <category>Pulmonary Arterial Hypertension Market</category>
      <category>PAH Market Size</category>
      <category>PAH Therapeutics</category>
      <category>PAH Treatment Market</category>
      <category>Pulmonary Hypertension Drugs</category>
      <category>Endothelin Receptor Antagonists ERAs</category>
      <category>PDE5 Inhibitors</category>
      <category>Prostacyclin and Prostacyclin Analogs</category>
      <category>Soluble Guanylate Cyclase sGC Stimulators</category>
      <category>Vasodilators</category>
      <category>Oral PAH Therapy</category>
      <category>Intravenous PAH Drugs</category>
      <category>Subcutaneous Therapy</category>
      <category>Inhalational Therapy</category>
      <category>Branded PAH Drugs</category>
      <category>Generic PAH Drugs</category>
      <category>PAH Pipeline Analysis</category>
      <category>Rare Disease Market</category>
      <category>Orphan Drug</category>
      <category>Prostacyclin Pathway</category>
      <category>Nitric Oxide Pathway</category>
      <category>Endothelin Pathway</category>
      <category>Combination Therapy</category>
      <category>Targeted Therapies</category>
      <category>DiseaseModifying Therapies</category>
      <category>Sotatercept</category>
      <category>BMPR2 Signaling</category>
      <pubDate>Thu, 16 Oct 2025 08:03:25 GMT</pubDate>
      <guid>https://www.nextgeniqstats.com/news/Pulmonary-Arterial-Hypertension-Market-Size-Trends-2024-2035-Research-Report</guid>
    </item>
  </channel>
</rss>
